4/A//SEC Filing
Hall Justin 4/A
Accession 0001437749-19-020744
CIK 0001389545other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:29 PM ET
Size
8.0 KB
Accession
0001437749-19-020744
Insider Transaction Report
Form 4/AAmended
Hall Justin
General Counsel
Transactions
- Award
Common Stock
2019-06-10$2.02/sh+47,500$95,950→ 50,905 total - Sale
Common Stock
2019-06-10$3.03/sh−47,500$143,925→ 3,405 total - Exercise of In-Money
Stock Option (right to buy)
2019-06-10−47,500→ 0 totalExercise: $2.02From: 2019-05-31Exp: 2028-05-31→ Common Stock (47,500 underlying)
Footnotes (1)
- [F1]The amended Form 4 is being filed to show (1) the corresponding acquisition of common stock after the exercise of options in Table I and (2) the immediate sale of common stock after such exercise of options in Table I.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001663021
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:29 PM ET
- Size
- 8.0 KB